3-Chlorobenzenesulphonyl chloride → 3-Chloro-N-{2-methyl-6-(methyloxy)-3-[3-(methyloxy)phenyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide
反応式
[CH3:1][C:2]1[S:13][C:5]2[N:6]=[C:7]([O:11][CH3:12])[CH:8]=[C:9]([NH2:10])[C:4]=2[C:3]=1[C:14]1[CH:19]=[CH:18][CH:17]=[C:16]([O:20][CH3:21])[CH:15]=1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C.[Cl:32][C:33]1[CH:34]=[C:35]([S:39](Cl)(=[O:41])=[O:40])[CH:36]=[CH:37][CH:38]=1>C1COCC1>[Cl:32][C:33]1[CH:34]=[C:35]([S:39]([NH:10][C:9]2[CH:8]=[C:7]([O:11][CH3:12])[N:6]=[C:5]3[S:13][C:2]([CH3:1])=[C:3]([C:14]4[CH:19]=[CH:18][CH:17]=[C:16]([O:20][CH3:21])[CH:15]=4)[C:4]=23)(=[O:41])=[O:40])[CH:36]=[CH:37][CH:38]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 2-methyl-6-(methyloxy)-3-[3-(methyloxy)phenyl]thieno[2,3-b]pyridin-4-amine (Description 37) (16.5 mg, 0.055 mmol) in THF (0.5 mL) at −78° C. under a nitrogen atmosphere was added LiHMDS (1M solution in THF) (0.055 mL, 0.055 mmol). The solution was stirred at −78° C. for ca. 10 min before the addition of 3-chlorobenzenesulfonyl chloride (7.73 μL, 0.055 mmol). The reaction mixture was then warmed to RT under a nitrogen atmosphere overnight and was then partitioned between water and ethyl acetate (ca. 10 mL each). The aqueous layer was separated and re-extracted with ethyl acetate (ca. 10 mL). The combined organic layer was passed through phase separator and the solvent concentrated in vacuo. The residue was purified by MDAP (acidic conditions), to give the title compound (11 mg). LCMS (A) m/z: 475 [M+1]+, Rt 1.63 min (acidic).
後処理
- customwas then partitioned between water and ethyl acetate (ca. 10 mL each)
- customThe aqueous layer was separated
- extractionre-extracted with ethyl acetate (ca. 10 mL)
- concentrationthe solvent concentrated in vacuo
- customThe residue was purified by MDAP (acidic conditions)
出典と根拠
- ORDレコード
- ord-349f63cb3f2746fd804b2b70ef5dda9a
- 出典データセット
- uspto-grants-2015_05
- 特許番号
- US09029545B2
反応ノート
読み込み中…